These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 15175360)

  • 21. Apolipoprotein A-IV expression in mouse liver enhances triglyceride secretion and reduces hepatic lipid content by promoting very low density lipoprotein particle expansion.
    VerHague MA; Cheng D; Weinberg RB; Shelness GS
    Arterioscler Thromb Vasc Biol; 2013 Nov; 33(11):2501-8. PubMed ID: 24030551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apolipoprotein A-IV genetic polymorphism and its impact on quantitative traits in normoglycemic and non-insulin-dependent diabetic Hispanics from the San Luis Valley, Colorado.
    Kamboh MI; Iyengar S; Aston CE; Hamman RF; Ferrell RE
    Hum Biol; 1992 Aug; 64(4):605-16. PubMed ID: 1644426
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of the apolipoprotein A-IV Q360H polymorphism on postprandial plasma triglyceride clearance.
    Hockey KJ; Anderson RA; Cook VR; Hantgan RR; Weinberg RB
    J Lipid Res; 2001 Feb; 42(2):211-7. PubMed ID: 11181750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between ApoA-II -265T/C polymorphism and oxidative stress in patients with type 2 diabetes mellitus.
    Koohdani F; Sadrzadeh-Yeganeh H; Djalali M; Eshraghian M; Keramat L; Mansournia MA; Zamani E
    J Diabetes Complications; 2015; 29(7):908-12. PubMed ID: 26104730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The relationship between plasma apolipoprotein A-IV levels and coronary heart disease.
    Manpuya MW; Guo J; Zhao Y
    Chin Med J (Engl); 2001 Mar; 114(3):275-9. PubMed ID: 11780313
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification and characterization of a rare variant in apolipoprotein A-IV, p.(V336M), and evaluation of HDL functionality in a Greek cohort with extreme HDL cholesterol levels.
    Chroni A; Rallidis L; Vassou D; Gkolfinopoulou C; Papakosta P; Zervou MI; Goulielmos GN; Kiouri E; Pappa D; Eliopoulos E; Kardassis D
    Arch Biochem Biophys; 2020 Dec; 696():108655. PubMed ID: 33130088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of apolipoprotein A-IV genotype and dietary fat on cholesterol absorption in humans.
    Weinberg RB; Geissinger BW; Kasala K; Hockey KJ; Terry JG; Easter L; Crouse JR
    J Lipid Res; 2000 Dec; 41(12):2035-41. PubMed ID: 11108737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of human apolipoprotein A-I/C-III/A-IV gene cluster in mice induces hyperlipidemia but reduces atherogenesis.
    Vergnes L; Baroukh N; Ostos MA; Castro G; Duverger N; Nanjee MN; Najib J; Fruchart JC; Miller NE; Zakin MM; Ochoa A
    Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):2267-74. PubMed ID: 11031214
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apolipoprotein A-IV polymorphism and its effect on plasma lipid and apolipoprotein concentrations.
    de Knijff P; Rosseneu M; Beisiegel U; de Keersgieter W; Frants RR; Havekes LM
    J Lipid Res; 1988 Dec; 29(12):1621-7. PubMed ID: 3244013
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction between the uncoupling protein 2 -866G>A gene variant and cigarette smoking to increase oxidative stress in subjects with diabetes.
    Stephens JW; Dhamrait SS; Mani AR; Acharya J; Moore K; Hurel SJ; Humphries SE
    Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):7-14. PubMed ID: 17555951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apolipoprotein A-IV is an independent predictor of disease activity in patients with inflammatory bowel disease.
    Broedl UC; Schachinger V; Lingenhel A; Lehrke M; Stark R; Seibold F; Göke B; Kronenberg F; Parhofer KG; Konrad-Zerna A
    Inflamm Bowel Dis; 2007 Apr; 13(4):391-7. PubMed ID: 17206692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The relationship among apolipoprotein(a) polymorphisms, the low-density lipoprotein receptor-related protein, and the very low density lipoprotein receptor genes, and plasma lipoprotein(A) concentration in the Czech population.
    Benes P; Muzík J; Benedík J; Znojil V; Vácha J
    Hum Biol; 2002 Feb; 74(1):129-36. PubMed ID: 11931574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-apolipoprotein A-1 autoantibodies as risk biomarker for cardiovascular diseases in type 2 diabetes mellitus.
    El-Lebedy D; Rasheed E; Kafoury M; Abd-El Haleem D; Awadallah E; Ashmawy I
    J Diabetes Complications; 2016; 30(4):580-5. PubMed ID: 26965796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ApoA-IV polymorphism associated with myocardial infarction in obese NIDDM patients. The San Luis Valley Diabetes Study.
    Rewers M; Kamboh MI; Hoag S; Shetterly SM; Ferrell RE; Hamman RF
    Diabetes; 1994 Dec; 43(12):1485-9. PubMed ID: 7958503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid in vivo transport and catabolism of human apolipoprotein A-IV-1 and slower catabolism of the apoA-IV-2 isoprotein.
    Rader DJ; Schäfer J; Lohse P; Verges B; Kindt M; Zech LA; Steinmetz A; Brewer HB
    J Clin Invest; 1993 Aug; 92(2):1009-17. PubMed ID: 8349786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apolipoprotein A4-1/2 polymorphism and response of serum lipids to dietary cholesterol in humans.
    Weggemans RM; Zock PL; Meyboom S; Funke H; Katan MB
    J Lipid Res; 2000 Oct; 41(10):1623-8. PubMed ID: 11013304
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apolipoprotein A-IV levels and phenotype distribution in NIDDM.
    Vergès BL; Vaillant G; Goux A; Lagrost L; Brun JM; Gambert P
    Diabetes Care; 1994 Aug; 17(8):810-7. PubMed ID: 7956623
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An interaction between the interleukin-6 -174G>C gene variant and urinary protein excretion influences plasma oxidative stress in subjects with type 2 diabetes.
    Stephens JW; Hurel SJ; Acharya J; Humphries SE
    Cardiovasc Diabetol; 2004 Mar; 3():2. PubMed ID: 14992698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI.
    Rubin EM; Krauss RM; Spangler EA; Verstuyft JG; Clift SM
    Nature; 1991 Sep; 353(6341):265-7. PubMed ID: 1910153
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Macrovascular disease is associated with increased plasma apolipoprotein A-IV levels in NIDDM.
    Vergès BL; Lagrost L; Vaillant G; Petit JM; Cohen M; Gambert P; Brun JM
    Diabetes; 1997 Jan; 46(1):125-32. PubMed ID: 8971092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.